(Q35834662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Economic aspects of pneumococcal pneumonia: a review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

pneumococcal pneumonia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Philippe Beutels

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

1 reference

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

719-740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15250750%20AND%20SRC:MED&resulttype=core&format=json

Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas

30 December 2019

cites work

1 reference

12 December 2020

The burden of community-acquired pneumonia in Spain.

1 reference

12 December 2020

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

1 reference

12 December 2020

Cost-effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps

1 reference

12 December 2020

Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis

1 reference

12 December 2020

Pneumococcal pneumonia: epidemiology and clinical features.

1 reference

12 December 2020

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

1 reference

12 December 2020

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

1 reference

12 December 2020

The pneumococcal problem

1 reference

12 December 2020

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence

1 reference

12 December 2020

Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin

1 reference

12 December 2020

A cost-effectiveness analysis of pneumococcal vaccination in street-involved, HIV-infected patients

1 reference

12 December 2020

Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries

1 reference

12 December 2020

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

1 reference

12 December 2020

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia

1 reference

12 December 2020

Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine

1 reference

12 December 2020

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

12 December 2020

Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.

1 reference

12 December 2020

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

12 December 2020

An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.

1 reference

12 December 2020

Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections

1 reference

12 December 2020

Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?

1 reference

12 December 2020

Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis

1 reference

12 December 2020

Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study.

1 reference

12 December 2020

Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults

1 reference

12 December 2020

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

1 reference

12 December 2020

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

12 December 2020

Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia

1 reference

12 December 2020

Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia

1 reference

12 December 2020

Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia

1 reference

12 December 2020

A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

1 reference

12 December 2020

Economic evaluations of adult pneumococcal vaccination strategies

1 reference

12 December 2020

Clinical and economic outcomes of empiric parenteral antibiotic therapy for pneumonia: a retrospective study of 1,032 hospitalized patients

1 reference

12 December 2020

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

12 December 2020

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

1 reference

12 December 2020

Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium.

1 reference

12 December 2020

Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines

1 reference

12 December 2020

Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.

1 reference

12 December 2020

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence

1 reference

12 December 2020

Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia

1 reference

12 December 2020

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

12 December 2020

The cost of treating community-acquired pneumonia.

1 reference

12 December 2020

Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.

1 reference

12 December 2020

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

12 December 2020

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

12 December 2020

Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

1 reference

12 December 2020